메뉴 건너뛰기




Volumn 8, Issue 6, 2008, Pages 589-593

Acute renal insufficiency, supraventricular tachycardia, and confusion after recombinant human bone morphogenetic protein-2 implantation for lumbosacral spine fusion: Case report

Author keywords

Adverse reaction; Arrhythmia; Renal failure; rhBMP 2; Spinal fusion

Indexed keywords

PROTEIN ANTIBODY; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2 ANTIBODY;

EID: 45149115102     PISSN: 15475654     EISSN: 15475646     Source Type: Journal    
DOI: 10.3171/SPI/2008/8/6/589     Document Type: Article
Times cited : (6)

References (20)
  • 1
    • 0033954803 scopus 로고    scopus 로고
    • The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report
    • Boden SD, Zdeblick TA, Sandhu HS, Heim SE: The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 25:376-381, 2000
    • (2000) Spine , vol.25 , pp. 376-381
    • Boden, S.D.1    Zdeblick, T.A.2    Sandhu, H.S.3    Heim, S.E.4
  • 2
    • 9244230646 scopus 로고    scopus 로고
    • Bovine collagen induced systemic symptoms: Antibody formation against bovine and human collagen
    • Bonnet C, Charriere G, Vaquier J, Bertin P, Vergne P, Treves R: Bovine collagen induced systemic symptoms: antibody formation against bovine and human collagen. J Rheumatol 23:545-547, 1996
    • (1996) J Rheumatol , vol.23 , pp. 545-547
    • Bonnet, C.1    Charriere, G.2    Vaquier, J.3    Bertin, P.4    Vergne, P.5    Treves, R.6
  • 5
    • 0021338291 scopus 로고
    • The immunogenicity of injectable collagen. I. A 1-year prospective study
    • Cooperman L, Michaeli D: The immunogenicity of injectable collagen. I. A 1-year prospective study. J Am Acad Dermatol 10:638-646, 1984
    • (1984) J Am Acad Dermatol , vol.10 , pp. 638-646
    • Cooperman, L.1    Michaeli, D.2
  • 6
    • 0021348522 scopus 로고
    • The immunogenicity of injectable collagen. II. A retrospective review of seventy-two tested and treated patients
    • Cooperman L, Michaeli D: The immunogenicity of injectable collagen. II. A retrospective review of seventy-two tested and treated patients. J Am Acad Dermatol 10:647-651, 1984
    • (1984) J Am Acad Dermatol , vol.10 , pp. 647-651
    • Cooperman, L.1    Michaeli, D.2
  • 7
    • 0025066426 scopus 로고
    • Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives
    • DeLustro F, Dasch J, Keefe J, Ellingsworth L: Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin Orthop Relat Res 260:263-279, 1990
    • (1990) Clin Orthop Relat Res , vol.260 , pp. 263-279
    • DeLustro, F.1    Dasch, J.2    Keefe, J.3    Ellingsworth, L.4
  • 8
    • 33750290922 scopus 로고    scopus 로고
    • Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft
    • Dimar JR, Glassman SD, Burkus KJ, Carreon LY: Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 31:2534-2540, 2006
    • (2006) Spine , vol.31 , pp. 2534-2540
    • Dimar, J.R.1    Glassman, S.D.2    Burkus, K.J.3    Carreon, L.Y.4
  • 11
    • 0038694884 scopus 로고    scopus 로고
    • BMP-2 regulates cardiomyocyte contractility in a phosphatidylinositol 3 kinase-dependent manner
    • Ghosh-Choudhury N, Abboud SL, Chandrasekar B, Ghosh Choudhury G: BMP-2 regulates cardiomyocyte contractility in a phosphatidylinositol 3 kinase-dependent manner. FEBS Lett 544:181-184, 2003
    • (2003) FEBS Lett , vol.544 , pp. 181-184
    • Ghosh-Choudhury, N.1    Abboud, S.L.2    Chandrasekar, B.3    Ghosh Choudhury, G.4
  • 12
    • 0026521642 scopus 로고
    • Clinical use of injectable bovine collagen: A decade of experience
    • Keefe J, Wauk L, Chu S, DeLustro F: Clinical use of injectable bovine collagen: a decade of experience. Clin Mater 9:155-162, 1992
    • (1992) Clin Mater , vol.9 , pp. 155-162
    • Keefe, J.1    Wauk, L.2    Chu, S.3    DeLustro, F.4
  • 14
    • 0037102590 scopus 로고    scopus 로고
    • Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications
    • McKay B, Sandhu HS: Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications. Spine 27 (16 Suppl):S66-S85, 2002
    • (2002) Spine , vol.27 , Issue.16 SUPPL.
    • McKay, B.1    Sandhu, H.S.2
  • 15
    • 0037102257 scopus 로고    scopus 로고
    • Safety profile for the clinical use of bone morphogenetic proteins in the spine
    • Poynton AR, Lane JM: Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 27 (16 Suppl):S40-S48, 2002
    • (2002) Spine , vol.27 , Issue.16 SUPPL.
    • Poynton, A.R.1    Lane, J.M.2
  • 16
    • 0021355689 scopus 로고
    • Intradermal implantation of bovine collagen. Humoral immune responses associated with clinical reactions
    • Siegle RJ, McCoy JP Jr, Schade W, Swanson NA: Intradermal implantation of bovine collagen. Humoral immune responses associated with clinical reactions. Arch Dermatol 120:183-187, 1984
    • (1984) Arch Dermatol , vol.120 , pp. 183-187
    • Siegle, R.J.1    McCoy Jr, J.P.2    Schade, W.3    Swanson, N.A.4
  • 17
    • 2542432258 scopus 로고    scopus 로고
    • Development of a novel nonantigenic dermal implant composed of human placental collagen
    • Toman PD, Egbert BM, Thomas JA, DeLustro FA: Development of a novel nonantigenic dermal implant composed of human placental collagen. Plast Reconstr Surg 113:1015-1023, 2004
    • (2004) Plast Reconstr Surg , vol.113 , pp. 1015-1023
    • Toman, P.D.1    Egbert, B.M.2    Thomas, J.A.3    DeLustro, F.A.4
  • 18
  • 19
    • 19444374220 scopus 로고    scopus 로고
    • Bone morphogenetic proteins and spinal fusion
    • Walker DH, Wright NM: Bone morphogenetic proteins and spinal fusion. Neurosurg Focus 13(6):E3, 2002
    • (2002) Neurosurg Focus , vol.13 , Issue.6
    • Walker, D.H.1    Wright, N.M.2
  • 20
    • 34047221104 scopus 로고    scopus 로고
    • Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility
    • Wang YX, Qian LX, Liu D, Yao LL, Jiang Q, Yu Z, et al: Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility. Cardiovasc Res 74:290-303, 2007
    • (2007) Cardiovasc Res , vol.74 , pp. 290-303
    • Wang, Y.X.1    Qian, L.X.2    Liu, D.3    Yao, L.L.4    Jiang, Q.5    Yu, Z.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.